Preclinical development of [(89)Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas Meeting Abstract
| Authors: | Herrero Alvarez, N.; Lewis, J. |
| Abstract Title: | Preclinical development of [(89)Zr]Zr-DFO-Isatuximab as a novel immunoPET tracer for CD38-targeted imaging of multiple myeloma and lymphomas |
| Meeting Title: | International Symposium on Radiopharmaceutical Sciences (iSRS 2022) |
| Journal Title: | Nuclear Medicine and Biology |
| Volume: | 108-109 |
| Issue: | Suppl. |
| Meeting Dates: | 2022 May 29-Jun2 |
| Meeting Location: | Nantes, France |
| ISSN: | 0969-8051 |
| Publisher: | Elsevier Science Inc. |
| Date Published: | 2022-05-01 |
| Start Page: | S192 |
| End Page: | S193 |
| Language: | English |
| ACCESSION: | WOS:000802721400345 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0969-8051(22)00399-7 |
| Notes: | Meeting Abstract: P262 -- Listed under section named "Poster Presentations: Applications of radiolabeled compounds in oncology" -- Source: Wos |
